HealthcareServices

Clinical Trial Software Market Size Forecast: Revenue and CAGR by 2029

November 27, 2025 by Marketing Posting

Unlock Global Insights – Save 20% on Market Reports with Code ONLINE20

What Market Value Is The Clinical Trial Software Industry Expected To Reach By 2029, Starting From 2025 Levels?

The clinical trial software market has seen rapid expansion in recent years. It is anticipated to increase from $1.16 billion in 2024 to $1.32 billion in 2025, reflecting a compound annual growth rate (CAGR) of 14.1%. This historical growth can be attributed to a surge in demand for new software, broader adoption of emerging technologies, enhanced digitalization in clinical trials, expanding use of cloud computing, and an increasing presence of small and mid-size biopharmaceutical companies.

The clinical trial software market is projected for swift expansion over the coming years. Its valuation is anticipated to reach $2.23 billion by 2029, exhibiting a compound annual growth rate (CAGR) of 13.9%. This expansion during the projection period stems from increased clinical research endeavors, the growing appeal of virtual trials, an escalating need for patient-focused clinical trial solutions, rising demand for specialized medicines, and a higher incidence of venous conditions. Key developments expected during the forecast timeframe encompass technological advancements, artificial intelligence (AI), progress and novelties in technologies, artificial intelligence and machine learning, alongside integration with real-world data sources.

Unlock Your Free Sample Report for Exclusive Market Data:

https://www.thebusinessresearchcompany.com/sample.aspx?id=21150&type=smp

What Are The Main Drivers Boosting The Clinical Trial Software Industry’s Expansion?

An uplift in research and development activities is anticipated to fuel the expansion of the clinical trial software market. Research and development activities encompass a systematic method of exploring, devising, and evaluating novel products or technologies with the goal of innovating, enhancing existing solutions, or introducing entirely new offerings. These activities are on the rise due to a heightened demand for innovation across various industries, propelled by technological advancements, competitive pressures within markets, and the imperative for sustainable solutions, which in turn motivate organizations to allocate more resources towards developing new products, processes, and services. Clinical trial software facilitates research and development by optimizing the planning, execution, and administration of clinical trials, essential for assessing new drugs and therapies. For instance, in April 2024, the Office for National Statistics, a UK-based government department, reported that the UK government’s spending on research and development in 2022 climbed to £15.5 ($19.67) billion from £14.0 ($17.77) billion in 2021, indicating a 10.5% growth. Thus, the growing investment in research and development activities acts as a primary driver for the clinical trial software market’s growth.

What Are The Primary Types Of Segments Analyzed In The Clinical Trial Software Market?

The clinical trial softwaremarket covered in this report is segmented –

1) By Deployment: On-Premises; Web-Based Clinical Trial Software; Cloud-Based Clinical Trial Software; Other Deployments

2) By Software: Electronic Data Capture (EDC); Electronic Clinical Outcome Assessment (eCOA) Or Electronic Patient-Reported Outcome (ePRO); Electronic Informed Consent

3) By End-User: Pharmaceutical And Biotechnology Companies; Contract Research Organizations (CROs); Medical Device Manufacturers; Other End-Users

Subsegments:

1) By On-Premises: Enterprise Clinical Trial Management Systems; Site-Based Clinical Trial Solutions

2) By Web-Based Clinical Trial Software: Electronic Data Capture (EDC) Systems; Clinical Trial Management Systems (CTMS); Randomization And Trial Supply Management (RTSM)

3) By Cloud-Based Clinical Trial Software: Software-as-a-Service (SaaS) Platforms; AI-Powered Clinical Trial Solutions; Remote Monitoring And Decentralized Trial Systems

4) By Other Deployments: Hybrid Clinical Trial Solutions; Custom-Built Clinical Trial Software

What Long-Term Trends Will Shape The Future Growth Of The Clinical Trial Software Industry?

Leading companies in the clinical trial software market are dedicated to developing advanced technologies, such as integrated trial solutions, aimed at enhancing data collection and integration, fostering improved patient engagement, streamlining trial procedures, reducing costs, and accelerating the overall drug development timeline. An integrated trial solution refers to a comprehensive digital platform crafted to optimize and enhance the clinical trial process. For instance, in November 2023, AstraZeneca plc, a pharmaceutical company based in the UK, introduced Evinova to empower AI in clinical research. This innovative platform boasts distinctive features like automated patient recruitment, which employs AI algorithms to swiftly align candidates with trial criteria, thereby significantly shortening enrollment times. It also incorporates predictive modeling tools that analyze past and current data to forecast patient responses, thereby improving the design and efficiency of trials. Its user-friendly interface encourages better patient participation by offering digital platforms for communication and feedback, allowing participants to more easily share their experiences.

Who Are The Top Performing Companies In The Clinical Trial Software Market In Recent Years?

Major companies operating in the clinical trial software market are International Business Machines Corporation, Oracle Corporation, Wipro Limited, Veeva Systems, Medpace Holdings Inc., Medidata Solutions, Signant Health Inc., Clario Inc., Advarra Inc., Celerion Inc., Veristat LLC, Greenphire Inc., Medrio Inc., Arisglobal LLC, Anju Software Inc., ClinCapture Inc., Palleos Healthcare GmbH, OpenClinica LLC, Pharmaseal International Limited, SoftFormance

Download The Full Report For Exclusive Market Findings:

https://www.thebusinessresearchcompany.com/report/clinical-trial-software-global-market-report

Which Region Shows The Highest Potential For Future Expansion In The Clinical Trial Software Market?

North America was the largest region in the clinical trial software market in 2024. Europe is expected to be the fastest-growing region in the forecast period. The regions covered in the clinical trial software market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Version Of The Clinical Trial Software Market Report:

https://www.thebusinessresearchcompany.com/customise?id=21150&type=smp

Browse Through More Reports Similar to the Global Clinical Trial Software Market 2025, By The Business Research Company

Clinical Workflow Solutions Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/clinical-workflow-solutions-global-market-report

Clinical Decision Support Systems Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/clinical-decision-support-systems-global-market-report

Clinical Chemistry Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/clinical-chemistry-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795